Published October 2021
| Version v1
Journal article
The Role of Adjuvant Chemoradiotherapy in Nonhilar Extrahepatic Bile Duct Cancer: A Long-Term Single-Institution Analysis
Creators
- 1. Department of Radiation Oncology, Seoul National University College of Medicine (Korea, Republic of)
- 2. Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University, Boramae Medical Center (Korea, Republic of)
- 3. Department of Radiation Oncology, Ewha Womans University College of Medicine (United States)
- 4. Department of Internal Medicine, Seoul National University College of Medicine (Korea, Republic of)
- 5. Department of Surgery, Seoul National University College of Medicine (Korea, Republic of)
- 6. Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul (Korea, Republic of)
Description
Despite frequent use in the clinical setting, especially for patients with high-risk factors for relapse, the role of adjuvant treatment has not been clarified in nonhilar extrahepatic bile duct cancer (NH-EHBDC). The goal of this study is to identify the role of adjuvant chemoradiotherapy (CRT) in NH-EHBDC patients after radical surgery.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2021.05.012Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2021.05.012;
- PII
- S0360301621005423;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 111
- Journal Issue
- 2
- Journal Page Range
- p. 395-404
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53124682
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BILIARY TRACT; COMBINED THERAPY; HEALTH HAZARDS; NEOPLASMS; PATIENTS; SURGERY
- Descriptors DEC
- DIGESTIVE SYSTEM; DISEASES; HAZARDS; MEDICINE; THERAPY
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier Inc. All rights reserved.